
Sigla Sciences is a strategic consultancy and creative agency specializing in life sciences, focusing on market access, HEOR, commercial launch, and digital engagement. They serve biopharmaceutical, diagnostics, device, and digital health tech companies, particularly in oncology, rare diseases, and cell & gene therapies. Their business model is a lean, cost-efficient consultancy leveraging a global expert network to deliver high-impact strategies and tactics including pricing, reimbursement, alliance building, and omnichannel outreach. They differentiate by combining deep industry expertise with cutting-edge digital and AI-driven approaches, enabling clients to optimize market position and launch success. Their traction includes successful deployments of payer stories, market access toolkits, outcomes-based agreements, and educational campaigns for leading biopharma clients, demonstrating strong market impact and client satisfaction.

Sigla Sciences is a strategic consultancy and creative agency specializing in life sciences, focusing on market access, HEOR, commercial launch, and digital engagement. They serve biopharmaceutical, diagnostics, device, and digital health tech companies, particularly in oncology, rare diseases, and cell & gene therapies. Their business model is a lean, cost-efficient consultancy leveraging a global expert network to deliver high-impact strategies and tactics including pricing, reimbursement, alliance building, and omnichannel outreach. They differentiate by combining deep industry expertise with cutting-edge digital and AI-driven approaches, enabling clients to optimize market position and launch success. Their traction includes successful deployments of payer stories, market access toolkits, outcomes-based agreements, and educational campaigns for leading biopharma clients, demonstrating strong market impact and client satisfaction.